CSE: SONA | OTCQB: SNANF
   +1-902-442-0653   Purdy’s Wharf Tower II Suite 2001 – 1969 Upper Water Street

Category: News Releases

News & Media — News Releases

News Releases

Sona Nanotech to Arrange Private Placement Financing
July 31, 2024

Sona Nanotech to Arrange Private Placement Financing
Sona’s Cancer Therapy Triggers Abscopal Effect, Eliminating Distant Tumors In Preclinical Melanoma Study
June 26, 2024

Sona’s Cancer Therapy Triggers Abscopal Effect, Eliminating Distant Tumors In Preclinical Melanoma Study
Sona’s Therapy Shows Significant Preclinical Efficacy in Second Cancer
June 20, 2024

Sona’s Therapy Shows Significant Preclinical Efficacy in Second Cancer
Sona Appoints Chief Medical Officer and Files Provisional Conjugation Patent
May 21, 2024

Sona Appoints Chief Medical Officer and Files Provisional Conjugation Patent
Sona’s Cancer Therapy Creates a Systemic Immune Response in Murine Breast Cancer Model
April 29, 2024

Sona’s Cancer Therapy Creates a Systemic Immune Response in Murine Breast Cancer Model
April 12, 2024

Sona Nanotech Provides Interim Results of Dalhousie Efficacy Study
Sona Nanotech Secures Grant Funding to Support Intellectual Property Strategy and Development
April 8, 2024

Sona Nanotech Secures Grant Funding to Support Intellectual Property Strategy and Development
Sona Nanotech Updates on Dalhousie Efficacy Study and New NCL Results
March 25, 2024

Sona Nanotech Updates on Dalhousie Efficacy Study and New NCL Results
Sona Nanotech Announces Filing of Provisional Patent Application
March 18, 2024

Sona Nanotech Announces Filing of Provisional Patent Application
Sona Nanotech Grants Options
March 1, 2024

Sona Nanotech Grants Options
Load More
Subscribe